ROBERT L. VAN NOSTRAND - 31 Mar 2023 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC. (YTEN)

Role
Director
Signature
/s/ Charles B. Haaser, attorney-in-Fact
Issuer symbol
YTEN
Transactions as of
31 Mar 2023
Transactions value $
$0
Form type
4
Filing time
04 Apr 2023, 17:24:59 UTC
Previous filing
03 Feb 2023
Next filing
19 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YTEN Common Stock Award $0 +1,642 +5.82% $0 1,924 31 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $4,531 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the first quarter of 2023.